Evidence-Based Medicine Guidelines
Trastuzumab containing regimens for early breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Trastuzumab Containing Regimens for Early Breast Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457534/all/Trastuzumab_containing_regimens_for_early_breast_cancer.
Trastuzumab containing regimens for early breast cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457534/all/Trastuzumab_containing_regimens_for_early_breast_cancer. Accessed November 28, 2023.
Trastuzumab containing regimens for early breast cancer. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457534/all/Trastuzumab_containing_regimens_for_early_breast_cancer
Trastuzumab Containing Regimens for Early Breast Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 November 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457534/all/Trastuzumab_containing_regimens_for_early_breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Trastuzumab containing regimens for early breast cancer
ID - 457534
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457534/all/Trastuzumab_containing_regimens_for_early_breast_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
